Ill. Admin. Code tit. 89, § 140.451 - Prospective Drug Review and Patient Counseling
Each pharmacy must ensure that:
a) The requirements for patient counseling
established by the Illinois Department of Professional Regulation at 68 Ill.
Adm. Code 1330.65, including the requirements of confidentiality and
documentation of refusal of offers of patient counseling by recipients, are met
on a continuing basis.
b) Before
each prescription is delivered to the recipient or the recipient's care giver,
a pharmacist must ensure that a review of the recipient's drug therapy
(prospective drug review or drug utilization evaluation) was performed using
commonly accepted drug review criteria. The review must include screening to
identify potential drug therapy problems of the following types:
1) Therapeutic duplication, including the
prescribing and dispensing of two or more drugs from the same therapeutic class
such that the combined daily dose puts the recipient at risk of an adverse
medical result or incurs additional program costs without additional
therapeutic benefit;
2)
Drug-disease contraindication when there is the potential for, or the
occurrence of, an undesirable alteration of the therapeutic effect of a given
drug because of the presence of a disease condition known to the pharmacist or
that may reasonably be expected to be known to the pharmacist, or an adverse
effect of the drug on the patient's disease condition;
3) Adverse drug-drug interaction when there
is the potential for, or occurrence of, a clinically significant adverse
medical effect as the result of the recipient using two or more drugs
together;
4) Perceived incorrect
drug dosage or duration; and
5)
Drug-allergy interactions.
c) Commonly accepted drug review criteria are
those criteria that are consistent with peer-reviewed medical literature (that
is, scientific, medical and pharmaceutical publications in which original
manuscripts are rejected or published only after having been critically
reviewed by unbiased independent experts) and the following compendia:
1) American Hospital Formulary Service Drug
Information;
2) United States
Pharmacopeia-Drug Information;
3)
American Medical Association Drug Evaluations;
4) DRUG DEX Information System; and
5) Facts and Comparisons.
Notes
Added at 22 Ill. Reg. 16302, effective August 28, 1998
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.